Determination of transition zone volume by transrectal ultrasound in patients with clinically benign prostatic hyperplasia: Agreement with enucleated prostate adenoma weight

Journal of Urology

Volumn 164, Issue 1, 2000, Pages 72-75

  Baltaci, Sümer ^a   Yagci, Cemil ^a   Aksoy, Hakan ^a   Elhan, Atilla H ^a   Göǧüs, Orhan ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Adenoma; Prostate; Prostatic hyperplasia; Ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; HUMAN; MALE; MEASUREMENT; PRIORITY JOURNAL; PROSTATE ADENOMA; PROSTATE HYPERTROPHY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0033931734     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67452-6     Document Type: Article

References (11)

1. McNeal, J. E.: Normal histology of the prostate. Am J Surg Pathol, 12: 619, 1988
2. Lepor, H., Wang, B. and Shapiro, E.: Relationship between prostatic epithelial volume and serum prostate-specific antigen levels. Urology, 44: 199, 1994
3. Kalish, J., Cooner, W. H. and Graham, S. D.: Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology, 43: 601, 1994
4. Zlotta, A. R., Djavan, B., Marberger, M. et al: Prostate specific-antigen density of the transition zone: a new effective parameter for prostate cancer prediction. J Urol, 157: 1315, 1997
5. Terris, M. K., Afzal, N. and Kabalin, J. N.: Correlation of transrectal ultrasound measurements of prostate and transition zone size with symptom score, bother score, urinary flow rate, and post-void residual volume. Urology, 52: 462, 1998
6. Zlotta, A. R., Djavan, B., Petein, M. et al: Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng/ml. J Urol, 160: 2089, 1998
7. Kurita, Y., Suzuki, A., Masuda, H. et al: Transition zone volume-adjusted prostate-specific antigen value predicts extracapsular carcinoma of the prostate in patients with intermediate prostate-specific antigen levels. Eur Urol, 33: 32, 1998
8. Ohtani, T., Hayashi, Y., Kishino, T. et al: A new parameter in decision making for transurethral electroresection of benign prostate hyperplasia. Eur Urol, 35: 185, 1999
9. Greene, D. R., Egawa, S., Hellerstein, D. K. et al: Sonographic measurements of transition zone of prostate in men with and without benign prostatic hyperplasia. Urology, 36: 293, 1990
10. Zlotta, A. R., Djavan, B., Damoun, M. et al: The importance of measuring the prostatic transition zone: an anatomical and radiological study. BJU Int, 84: 661, 1999
11. Maeda, H., Arai, Y., Ishitoya, S. et al: Prostate specific antigen adjusted for the transition zone volume as an indicator of prostate cancer. J Urol, 158: 2193, 1997